• Lipase, Body Fluid
  • MEK1 Mutation Analysis, Melanoma
  • Bruton Tyrosine Kinase (BTK) Protein Expression by Flow Cytometry
  • Myelin Associated Glycoprotein (MAG) Antibody
  • Platelet Count
  • Histoplasma Antigen, Serum
  • Theophylline, Urine
  • Cardio Pharmacogenetics (PGx) Gene Variation Panel
  • T-Cell Antigen Receptor, Beta (TCRB) Gene Rearrangement Analysis for Abnormal Clonality, Applified Method
  • Calcium Channel Voltage-dependent L Type alpha 1S Subunit (CACNA1S) Gene Mutation Analysis
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Usher Syndrome, Types 1F and 3 (PCDH15 and CLRN1), 2 Variants
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Usher Syndrome, Types 1F and 3 (PCDH15 and CLRN1), 2 Variants
Medical Test

CPT
Access to Usher Syndrome, Types 1F and 3 (PCDH15 and CLRN1), 2 Variants is restricted.
Loading...